Prosight Management, LP
Top Portfolio Positions
46 positions ·
$609,819,830 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| NKTR |
Nektar Therapeutics
Healthcare
|
735,000 | $52,883,250 | 8.67% | |
| BSX |
Boston Scientific Corp
Healthcare
|
795,547 | $49,920,574 | 8.19% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
3,550,000 | $49,345,000 | 8.09% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
1,945,000 | $48,644,450 | 7.98% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
1,550,000 | $46,500,000 | 7.63% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
523,463 | $33,616,793 | 5.51% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
5,004,439 | $32,178,542 | 5.28% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
8,300,000 | $31,125,000 | 5.10% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
3,356,700 | $27,289,971 | 4.48% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
76,000 | $25,146,120 | 4.12% |
Portfolio Trend
25 quarters · across all stocks
Holdings in RNTX
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $535,080 | 411,600 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $513,416 | 442,600 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $650,243 | 567,898 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $599,086 | 427,919 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $761,100 | 430,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $931,451 | 404,979 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,317,435 | 372,157 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $734,050 | 265,000 | Shares | Sole | 2024-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||